C-RAD and ScandiDos Partner to Market Advanced Radiation Therapy in the USA

ScandiDos AB and C-RAD AB are two Swedish companies working in radiation therapy. Both companies are developing and marketing innovative solutions to improve quality and precision when treating patients with cancer.

The companies have decided to merge resources on the important US market with the objective to offer a complete program for high quality control to the clinics.

C-RAD is in the US marketing and selling two different systems for use in advanced radiation therapy:

The Catalyst system is based on a new generation hardware and software platform for high performance optical surface scanning and augmented reality through re-projection. Advanced and highly optimized algorithms for non-rigid registration and deformable models enable real-time assessment of patient positioning errors before and during treatment delivery. The C-RAD Sentinel system, based on laser technology, is offering advanced functionality for 4DCT.

ScandiDos is in the US marketing and selling the product family Delta⁴ to quality control advanced radiation therapy, from treatment plan to the last delivered treatment fraction.

ScandiDos introduced a paradigm shift in Radiation Therapy QA with real 3D and 4D dosimetry and thereby uniquely combine high quality measurements with time efficiency and clinical relevance.

Recently ScandiDos released the product HexaMotion for quality control in next generation radiation therapy, 4DRT and Delta^4DVH Anatomy to visualize measured dose in patient anatomy. ScandiDos will soon release Delta^4AT that uniquely address the patient dosimetry demand.